Aditxt (NASDAQ: ADTX) experienced a dramatic rally on Tuesday, with shares soaring 117% to close at $0.042. The surge followed a new SEC filing that revealed a significantly higher share count than previously reported on some retail platforms, raising questions about data accuracy and market valuation.
Share Count Discrepancy
According to Aditxt's filing on June 22, the company had 997,976,543 common shares outstanding. This figure is over 1,200 times higher than the approximately 816,000 shares listed on some free finance sites, such as Google Finance and Robinhood, which showed a market cap of around $32,670. Using Aditxt's official share count and Tuesday's closing price, the company's market capitalization stands at roughly $41.6 million.
Impact on Ownership Stakes
The updated share count dramatically reduces the size of reported major stakes. For instance, a Schedule 13D filing by Takeover Time 2026 LLC had indicated a 10.9% stake based on 3,420,439 shares purchased on June 12. However, with the new denominator, that stake is now approximately 0.34% of the company. Similarly, two passive-holder filings from Tai Wey Ann and Emil Cristian Burciu showed stakes of 12.3% and 5.5%, respectively, which now equate to roughly 0.01% and 0.005%.
Market Implications
For micro-cap traders, accurate data on market cap, float, and ownership is crucial. Outdated information can make a stock appear smaller, more thinly traded, or easier to take over than it actually is. This discrepancy could lead to misjudgments in trading decisions, especially for those relying on retail platforms that have not updated their figures.
Debt and SPAC Deal
Adding to the complexity, Aditxt recently increased its senior secured convertible note deal to $6.25 million in principal and sold additional notes for $500,000 cash. The debt is backed by assets of Ignite Proteomics and Aditxt's stake in Ignite. Furthermore, Aditxt has a pending SPAC deal to take Ignite public, valuing it at around $150 million. Jeff Busch, interim CEO of both Aditxt and Ignite, stated that Aditxt owns 100% of Ignite.
Broader Market Context
The rally in Aditxt was part of a broader move in healthcare micro-caps, with stocks like Atlantic International and Boundless Bio also seeing significant gains. However, Aditxt's move was tied to ownership and financing issues rather than clinical updates or earnings. The trade could reverse if buyers were expecting old ownership stakes, and the SPAC deal still requires shareholder approvals and regulatory sign-offs. Aditxt also noted that its Nasdaq listing remains contingent on compliance with exchange rules.
